CircDHDDS/miR-361-3p/WNT3A Axis Promotes the Development of Retinoblastoma by Regulating Proliferation, Cell Cycle, Migration, and Invasion of Retinoblastoma Cells.


Journal

Neurochemical research
ISSN: 1573-6903
Titre abrégé: Neurochem Res
Pays: United States
ID NLM: 7613461

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 03 01 2020
accepted: 13 08 2020
revised: 09 08 2020
pubmed: 1 9 2020
medline: 3 6 2021
entrez: 1 9 2020
Statut: ppublish

Résumé

Retinoblastoma (RB) is a common intraocular malignant tumor. The growing evidence has reported that circular RNAs (circRNAs) play critical roles in RB development. Therefore, the purpose of the study is to investigate the regulatory mechanism of circDHDDS in RB. The real-time quantitative polymerase chain reaction (RT-qPCR) assay was used to quantify the expression levels of circDHDDS, miR-361-3p, and WNT3A in RB tissues and cells (RPCs, Y-79, and WERI-Rb-1). The proliferation and cell cycle of RB cells were assessed by colony formation assay and flow cytometry assays, respectively. The migration and invasion of RB cells were measured by transwell assay. The protein expression levels of Nectin-3 (CD113), SOX2, Nanog, and WNT3A were measured by Western blot assay. The functional targets of circDHDDS and miR-361-3p were predicted by bioinformatics databases, and the dual-luciferase reporter assay was used to confirm the interaction relationship between miR-361-3p and circDHDDS or WNT3A. The functional role of circDHDDS silencing in vivo was evaluated by xenograft experiment. We found that circDHDDS was overexpressed in RB tissues and cells compared with normal retinas tissues and retinal pigment epithelial cells, correspondingly. Furthermore, silencing of circDHDDS impeded proliferation, migration, invasion, and induced cell cycle arrest in vitro, which were abolished by knockdown of miR-361-3p. The in vivo experiments also suggested that tumor growth was inhibited by knockdown of circDHDDS. Moreover, we also found that miR-361-3p specifically bound to WNT3A, and overexpression of miR-361-3p suppressed RB development by decreasing WNT3A expression. Summarily, circDHDDS, a molecule sponge of miR-361-3p, regulated the expression of WNT3A. Therefore, circDHDDS/miR-361-3p/WNT3A axis stimulated the development of RB by regulation of proliferation, cell cycle program, migration, and invasion of RB cells.

Identifiants

pubmed: 32865704
doi: 10.1007/s11064-020-03112-0
pii: 10.1007/s11064-020-03112-0
doi:

Substances chimiques

MIRN361 microRNA, human 0
MicroRNAs 0
RNA, Circular 0
WNT3A protein, human 0
Wnt3A Protein 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2691-2702

Références

Kivelä TT, Hadjistilianou T (2017) Neonatal retinoblastoma. Asia Pac J Oncol Nurs 4:197–204
doi: 10.4103/apjon.apjon_18_17
Ahmad A (2016) Retinoblastoma-clinical spectrum and treatment outcome in children. J Rawalpindi Med Coll 20:198–201
Gao J, Zeng J, Guo B, He W, Chen J, Lu F et al (2016) Clinical presentation and treatment outcome of retinoblastoma in children of South Western China. Medicine 95:e5204
doi: 10.1097/MD.0000000000005204
Waddell KM, Kagame K, Ndamira A, Twinamasiko A, Picton SV, Simmons IG et al (2015) Clinical features and survival among children with retinoblastoma in Uganda. Br J Ophthalmol 99:387–390
doi: 10.1136/bjophthalmol-2014-305564
Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A et al (2013) Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495:333
doi: 10.1038/nature11928
Yu T, Wang Y, Fan Y, Fang N, Wang T, Xu T et al (2019) CircRNAs in cancer metabolism: a review. J Hematol Oncol 12:90
doi: 10.1186/s13045-019-0776-8
Zhu L-P, He Y-J, Hou J-C, Chen X, Zhou S-Y, Yang S-J et al (2017) The role of circRNAs in cancers. Biosci Rep 37:BSR20170750
doi: 10.1042/BSR20170750
Lyu J, Wang Y, Zheng Q, Hua P, Zhu X, Li J et al (2019) Reduction of circular RNA expression associated with human retinoblastoma. Exp Eye Res 184:278–285
doi: 10.1016/j.exer.2019.03.017
Schirle NT, Sheu-Gruttadauria J, MacRae IJ (2014) Structural basis for microRNA targeting. Science 346(6209):608–613
doi: 10.1126/science.1258040
Farazi TA, Spitzer JI, Morozov P, Tuschl T (2011) miRNAs in human cancer. J Pathol 223:102–115
doi: 10.1002/path.2806
Chen W, Wang J, Liu S, Wang S, Cheng Y, Zhou W et al (2016) MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC. J Exp Clin Cancer Res 35:76
doi: 10.1186/s13046-016-0357-4
Liu S, Song L, Yao H, Zhang L, Xu D, Li Q et al (2018) Preserved miR-361-3p expression is an independent prognostic indicator of favorable survival in cervical cancer. Dis Mark. https://doi.org/10.1155/2018/8949606
doi: 10.1155/2018/8949606
Zhao D, Cui Z (2019) MicroRNA-361-3p regulates retinoblastoma cell proliferation and stemness by targeting hedgehog signaling. Exp Ther Med 17:1154–1162
pubmed: 30679988 pmcid: 30679988
Dzobo K, Thomford NE, Senthebane DA (2019) Targeting the versatile Wnt/β-catenin pathway in cancer biology and therapeutics: from concept to actionable strategy. OMICS 23(11):517–538
doi: 10.1089/omi.2019.0147
Liao YJ, Yin XL, Deng Y (2019) Peng XW (2019) PRC1 gene silencing inhibits proliferation, invasion, and angiogenesis of retinoblastoma cells through the inhibition of the Wnt/β-catenin signaling pathway. J Cell Biochem 120(10):16840–16852
doi: 10.1002/jcb.28942
Yun M-S, Kim S-E, Jeon SH, Lee J-S, Choi K-Y (2005) Both ERK and Wnt/β-catenin pathways are involved in Wnt3a-induced proliferation. J Cell Sci 118:313–322
doi: 10.1242/jcs.01601
He S, Lu Y, Liu X, Huang X, Keller ET, Qian C-N et al (2015) Wnt3a: functions and implications in cancer. Chin J Cancer 34:50
doi: 10.1186/s40880-015-0052-4
Zhang S, Chen X, Hu Y, Wu J, Cao Q, Chen S et al (2016) All-trans retinoic acid modulates Wnt3A-induced osteogenic differentiation of mesenchymal stem cells via activating the PI3K/AKT/GSK3β signalling pathway. Mol Cell Endocrinol 422:243–253
doi: 10.1016/j.mce.2015.12.018
Ni H, Chai P, Yu J, Xing Y, Wang S, Fan J et al (2020) LncRNA CANT1 suppresses retinoblastoma progression by repellinghistone methyltransferase in PI3Kγ promoter. Cell Death Dis 11(5):306
doi: 10.1038/s41419-020-2524-y
Pan Y, Ma S, Cao K et al (2018) Therapeutic approaches targeting cancer stem cells. J Cancer Res Ther 14(7):1469–1475
doi: 10.4103/jcrt.JCRT_976_17
Wang Z, Zhao Y, Wang Y, Jin C (2019) Circular RNA circHIAT1 inhibits cell growth in hepatocellular carcinoma by regulating miR-3171/PTEN axis. Biomed Pharmacother 116:108932
doi: 10.1016/j.biopha.2019.108932
Rong D, Sun H, Li Z, Liu S, Dong C, Fu K et al (2017) An emerging function of circRNA-miRNAs-mRNA axis in human diseases. Oncotarget 8:73271
doi: 10.18632/oncotarget.19154
Patop IL, Wüst S, Kadener S (2019) Past, present, and future of circRNAs. EMBO J 38(16):e100836
doi: 10.15252/embj.2018100836
Kim P, Park A, Han G, Sun H, Jia P, Zhao Z (2018) TissGDB: tissue-specific gene database in cancer. Nucleic Acids Res 46(D1):D1031–D1038
doi: 10.1093/nar/gkx850
Peter ME (2010) Targeting of mRNAs by multiple miRNAs: the next step. Oncogene 29(15):2161–2164
doi: 10.1038/onc.2010.59
Hu J, Li L, Chen H, Zhang G, Liu H, Kong R et al (2018) MiR-361-3p regulates ERK1/2-induced EMT via DUSP2 mRNA degradation in pancreatic ductal adenocarcinoma. Cell Death Dis 9:807
doi: 10.1038/s41419-018-0839-8
Ogawa H, Nakashiro KI, Tokuzen N, Kuribayashi N, Goda H, Uchida D (2020) MicroRNA-361-3p is a potent therapeutic target for oral squamous cell carcinoma. Cancer Sci 111(5):1645–1651
Pan L-H, Yao M, Cai Y, Gu J-J, Yang X-L, Wang L et al (2016) Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma. World J Gastroenterol 22:3829
doi: 10.3748/wjg.v22.i14.3829
Qi L, Sun B, Liu Z, Cheng R, Li Y, Zhao X (2014) Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression. J Exp Clin Cancer Res 33:107
doi: 10.1186/s13046-014-0107-4
Zhang B, Wang Q, Pan X (2007) MicroRNAs and their regulatory roles in animals and plants. J Cell Physiol 210:279–289
doi: 10.1002/jcp.20869
Lyu X, Wang L, Lu J, Zhang H, Wang L (2019) microRNA-485 inhibits the malignant behaviors of retinoblastoma by directly targeting Wnt3a. Oncol Rep 41:3137–3147
pubmed: 30896857
Yang Y, Zhao Z, Hou N, Li Y, Wang X, Wu F et al (2017) MicroRNA-214 targets Wnt3a to suppress liver cancer cell proliferation. Mol Med Rep 16:6920–6927
doi: 10.3892/mmr.2017.7483
Kaur N, Chettiar S, Rathod S, Rath P, Muzumdar D, Shaikh M et al (2013) Wnt3a mediated activation of Wnt/β-catenin signaling promotes tumor progression in glioblastoma. Mol Cell Neurosci 54:44–57
doi: 10.1016/j.mcn.2013.01.001

Auteurs

Hongjun Wang (H)

Department of Medical Administration, Shanghai Pudong Hospital, Shanghai, China.

Mingze Li (M)

Department of Ophthalmology, Shanghai Pudong Hospital, Shanghai, China.

Haibin Cui (H)

Department of Ophthalmology, Heilongjiang Eye Hospital, Harbin, Heilongjiang, China.

Xiangyuan Song (X)

Department of Ophthalmology, Shanghai Pudong Hospital, Shanghai, China.

Qian Sha (Q)

Department of Ophthalmology, Shanghai Pudong Hospital, Shanghai, China. qpm8v5@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH